Cavalier Jason Insider Trades

Insider Trading History

Track insider trading activity for Cavalier Jason. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lyra Therapeutics
Lyra Therapeutics LYRA
Principal Financial Officer
Holding Value $228k 517,880 shares
Last Trade
Apr 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$294 667 shares
$0.44
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $228k 518,547 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.58k 769 shares
$3.36
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $229k 519,316 shares
Last Trade
Jul 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.09k 684 shares
$8.91
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $229k 520,000 shares
Last Trade
Jan 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.22M 420,000 shares
$10.04
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $44k 100,000 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 100,000 shares
$12.01
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $88k 200,000 shares
Last Trade
Jan 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.8M 200,000 shares
$229.00
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $61.6k 140,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20M 140,000 shares
$142.50
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $6.87k 15,605 shares
Last Trade
Feb 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.73M 15,605 shares
$239.00
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Chief Financial Officer
Holding Value $45.8k 104,000 shares
Last Trade
Sep 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.7M 104,000 shares
$411.00
$0.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up